NextCure, Inc. (NXTC)
6.88
+0.30
(+4.56%)
USD |
NASDAQ |
Oct 15, 16:00
7.09
+0.21
(+3.05%)
After-Hours: 20:00
NextCure EPS Diluted (Quarterly) : -2.805 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.805 |
| March 31, 2026 | -1.870 |
| December 31, 2025 | -2.692 |
| September 30, 2025 | -3.223 |
| June 30, 2025 | -11.29 |
| March 31, 2025 | -0.3919 |
| December 31, 2024 | -4.972 |
| September 30, 2024 | -0.4125 |
| June 30, 2024 | -0.5507 |
| March 31, 2024 | -0.6131 |
| December 31, 2023 | -0.5184 |
| September 30, 2023 | -0.5137 |
| June 30, 2023 | -0.6418 |
| March 31, 2023 | -0.5795 |
| December 31, 2022 | -0.6229 |
| September 30, 2022 | -0.6815 |
| June 30, 2022 | -0.6459 |
| Date | Value |
|---|---|
| March 31, 2022 | -0.7435 |
| December 31, 2021 | -0.6128 |
| September 30, 2021 | -0.6493 |
| June 30, 2021 | -0.6515 |
| March 31, 2021 | -0.5991 |
| December 31, 2020 | -0.5608 |
| September 30, 2020 | -0.5941 |
| June 30, 2020 | -0.5272 |
| March 31, 2020 | 0.3316 |
| December 31, 2019 | -0.3974 |
| September 30, 2019 | -0.3713 |
| June 30, 2019 | -0.609 |
| March 31, 2019 | -0.271 |
| September 30, 2018 | -3.017 |
| June 30, 2018 | -0.2306 |
| March 31, 2018 | -0.22 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.89M |
| Total Expenses (Quarterly) | 14.89M |
| Enterprise Value | 12.19M |
| Earnings Yield | -153.9% |
| Normalized Earnings Yield | -144.18 |